Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIFIL: PET/CT in Invasive Pulmonary Aspergillosis
NCT02955966Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2017
- Primary completion
- May 2022
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Response rate according to 18F-FDG-PET/CT at 6 weeks. Started Jun 2017; status: completed.
Beyond the preview
Go deeper on NCT02955966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02955966.